ANNOUNCEMENT

MedCity CONVERGE July 9-10 in Philly gathers payers, providers, medtech, pharma, digital health, policymakers & more.

Sanofi says Gaucher disease pill meets goal in late-stage trial

October 2, 2012 1:17 am by | 0 Comments

PARIS (Reuters) - Sanofi's experimental pill to treat Gaucher disease, a rare inherited condition, has met its main goal in a late-stage trial, the French drugmaker said on Tuesday.

Patients treated with the drug, eliglustat tartrate, showed a statistically significant improvement in the size of their spleen after nine months compared with those who took a placebo, Sanofi said in a statement.

(Reporting by Elena Berton; Editing by Edwina Gibbs)

Copyright 2013 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
0 comments

Stay Up To Date

Recent Comments

Research Center

Jobs Board

Next Story
First Europe, now America: Lundbeck, Takeda seek FDA OK for antidepressant vortioxetine
Close